Statement Of Changes In Equity [Abstract]

Embla Medical hf - Filing #5889952

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity
759,112,000 USD
88,635,000 USD
4,829,000 USD
3,513,000 USD
777,186,000 USD
75,390,000 USD
780,699,000 USD
705,005,000 USD
699,667,000 USD
64,045,000 USD
3,123,000 USD
61,479,000 USD
4,781,000 USD
701,883,000 USD
635,510,000 USD
70,467,000 USD
194,000 USD
61,430,000 USD
639,961,000 USD
4,781,000 USD
635,704,000 USD
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)
68,278,000 USD
68,278,000 USD
682,000 USD
68,960,000 USD
58,801,000 USD
58,389,000 USD
412,000 USD
58,389,000 USD
Other comprehensive income
11,328,000 USD
6,706,000 USD
Comprehensive income
11,328,000 USD
56,950,000 USD
0 USD
0 USD
68,278,000 USD
682,000 USD
57,632,000 USD
65,507,000 USD
65,095,000 USD
6,706,000 USD
412,000 USD
58,389,000 USD
0 USD
0 USD
Issue of equity
27,204,000 USD
27,204,000 USD
Dividends recognised as distributions to owners
759,000 USD
0 USD
759,000 USD
Increase through other contributions by owners, equity
48,000 USD
27,156,000 USD
Decrease through other distributions to owners, equity
3,894,000 USD
229,000 USD
3,665,000 USD
229,000 USD
Increase (decrease) through other changes, equity
689,000 USD
689,000 USD
689,000 USD
825,000 USD
825,000 USD
825,000 USD
Increase (decrease) through share-based payment transactions, equity
602,000 USD
602,000 USD
602,000 USD
1,759,000 USD
1,759,000 USD
1,759,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.